• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

MBA: Is this the right decision for me?

Article

Many, if not most, ophthalmologists have at least entertained the idea of obtaining a master of business administration degree. This three-part series is designed to provide guidance through the process. The first steps involve the realization of goals, the return on investment, and the application process.

Key Points

Editor's Note: Parts two and three of this series will focus on topics such as balancing work and school commitments, choosing a major, networking, and putting an MBA to use.

With declining insurance reimbursements, increasingly burdensome administrative duties, and the possibility of some form of nationalized health-care looming on the horizon, many-if not most- ophthalmologists have at least entertained the idea of obtaining a master of business administration (MBA) degree. Their reasons are varied. For some, an MBA might help them move up the "corporate ladder"-perhaps to become a department chairperson. Others might be thinking "career change." Still, others simply might want more tools to manage their practices.

Whatever the reason, increasing numbers of ophthalmologists are taking the plunge and getting their MBAs. This three-part series is designed to help provide guidance through the process.

On the other hand, ophthalmologists who are in other specialties without a significant elective component, such as retina surgeons, might decide that those nonmedical business and marketing decisions are not significant. These physicians' decisions to obtain an MBA might be driven by other desires, such as becoming division chief or chairperson of an academic department or transitioning to industry.

Many physicians argue that having an MBA is becoming increasingly necessary with the changes in medicine. Eric Seaman, MD, a urologist, wrote in October 2004 in the Journal of the National Medical Association that he pursued an MBA because he believed that physicians were (and are) losing control of the ability to shape their destinies.

"Market forces, government initiatives, and certain lobbies continue to place more and more burden onto the shoulders of physicians," he wrote. One solution, according to Dr. Seaman, is for physicians to enhance their business knowledge.

My colleagues in academic medicine are pursuing an MBA in search of career advancement because many universities and other institutions are demanding that upper-level administrators not only have the academic credentials and clinical skills but also a business background (for example, an understanding of how to control costs, increase revenue).

Kelly Hutcheson, MD, associate professor of ophthalmology and pediatrics, Children's National Medical Center and George Washington University School of Medicine, Washington, DC, decided after a decade in academic medicine that her goal was to become more involved in the administration of the hospital and her department. To increase her professional worth, Dr. Hutcheson is obtaining her MBA at George Washington University part time. As part of the faculty, she receives a discount of up to 50% on her courses.

Yet another category of physicians who would be motivated to obtain an MBA are those who are considering a transition to investment banking (Wall Street), hedge funds, the pharmaceutical industry, or consulting. For example, when I was obtaining my MBA at New York University's (NYU) Leonard N. Stern School of Business as a part-time student from 2000 to 2004, I was considering transitioning to a management consulting firm. This new career offered better hours, a more attractive lifestyle, and higher income potential. To investigate this possibility further, I decided to go through the formal career placement track at NYU and interviewed with top management-consulting firms. I made it to the final round before I withdrew myself because I decided to remain in clinical medicine. The process was extremely useful, however, in providing a more complete picture of what my options outside of clinical medicine could be later in life as a second career.

Related Videos
 John Bladen, MBBS, BSc, MRCS, PGCert, PhD, FRCOphth, consultant ophthalmologist and oculoplastic surgeon, King's College Hospital NHS Foundation Trust, London, UK, speaks with Ophthalmology Times Europe's® Caroline Richards
rande, CFP, and John S. Grande, CFP, of Grande Financial Services, continue their discussion with Ophthalmology Times®' Sheryl Stevenson
What keeps you up at night?
S.K. Steven Houston III, MD, discusses retina innovations in use in his practice, including the NGENUITY 1.4 upgrade from Alcon
Caesar Luo, MD, shares his key take-aways on diabetic retinopathy progression in anti-VEGF versus FA implant
© 2024 MJH Life Sciences

All rights reserved.